GUANZE MEDICAL: SUPPLEMENTAL ANNOUNCEMENT TO THE ANNUAL REPORT AND THE ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023 REGARDING ADVANCES TO AN ENTITY
GUANZE MEDICAL (02427): The trustee purchased 2,536,000 shares on the market at a cost of HK$2,086,400
According to Zhitong Finance App News, GUANZE MEDICAL (02427) issued an announcement. On April 1, 2024, in accordance with the recommendations of the company's remuneration committee, the board of directors decided to award a total of 7.586 million bonus shares to 35 selected participants (all group employees) in accordance with the share award plan. Award shares are awarded at zero cost in accordance with the program rules and accepted by selected participants in accordance with the terms of the grant. The 7.586 million bonus shares granted to selected participants represented approximately 0.80% of the company's issued share capital as of the date of this announcement. According to the program rules, award shares can only be provided by a trustee or trust
GUANZE MEDICAL (02427.HK) grants a total of 7.586 million bonus shares
Gelonghui, May 8 | GUANZE MEDICAL (02427.HK) announced that on April 1, 2024, in accordance with the recommendations of the Company's Remuneration Committee, the board of directors decided to award a total of 7.586 million bonus shares to 35 selected participants (all employees of the Group) in accordance with the share award plan. Award shares are awarded at zero cost in accordance with the program rules and accepted by selected participants in accordance with the terms of the grant. The company was notified by the trustee that from April 2, 2024 to April 30, 2024, the trustee or trust holding company had purchased a total of 2,536 million shares in the market.
Guanze Medical Information's Profit Up in 2023
Guanze Medical Information (HKG:2427) recorded a rise in attributable profit for the year 2023 to 27.6 million yuan from 17.9 million yuan in 2022, according to the company's annual report posted on t
GUANZE MEDICAL:2023 年度報告
GUANZE MEDICAL (02427) will pay a final dividend of HK$0.021 per share on June 20
GUANZE MEDICAL (02427) announced that the company will do so on June 20, 2024...
GUANZE MEDICAL:截至2023年12月31日止年度之2023全年業績公告及建議修訂組織章程細則
GUANZE MEDICAL (02427.HK) will hold a board meeting on March 28 to approve the annual results
Gelonghui March 14 | GUANZE MEDICAL (02427.HK) announced that the company will hold a board meeting on March 28, 2024 to consider and approve the audited annual results of the company and its subsidiaries for the year ended 31 December 2023, and to declare a final dividend (if any).
GUANZE MEDICAL (02427.HK) Adopts Share Award Scheme
Gelonghui on December 3 | GUANZE MEDICAL (02427.HK) announced that on December 2, 2023, the board of directors decided to adopt the stock award plan. The board of directors may from time to time arrange for the payment of funds from the company to the trustee or trust holding company to purchase shares on the market, thereby paying for the rewards granted by the board of directors to selected participants in accordance with the program rules. A share reward scheme has been adopted, and only existing shares will be used for disbursement.
Changes in Hong Kong stocks | GUANZE MEDICAL (02427) rose more than 11% and surged 71% in the past 10 trading days, institutions say they are optimistic about Q4 investment opportunities in the pharmaceutical sector
GUANZE MEDICAL (02427) rose more than 11%, surging 71% in the past 10 trading days. As of press release, it rose 11.63% to HK$0.48, with a turnover of HK$1.61 million.
GUANZE MEDICAL: Interim Report 2023
GUANZE MEDICAL: CLARIFICATION ANNOUNCEMENT IN RELATION TO THE ANNOUNCEMENT OF INTERIM RESULTS FOR SIX MONTHS ENDED 30 JUNE 2023
GUANZE MEDICAL (02427) announced interim results, profit attributable to owners was 15.948 million yuan, up 4.13% year-on-year
GUANZE MEDICAL (02427) announced its 2023 interim results, with revenue of RMB 74...
GUANZE MEDICAL: ANNOUNCEMENT OF INTERIM RESULTS FOR SIX MONTHS ENDED 30 JUNE 2023
Changes in Hong Kong stocks | GUANZE MEDICAL (02427) rose more than 15%, institutions say pharmaceutical anti-corruption does not affect the investment value of the industry
GUANZE MEDICAL (02427) rose more than 15%. As of press release, it rose 13.51% to HK$0.42, with a turnover of HK$2.57 million.
GUANZE MEDICAL (02427.HK) plans to hold a board meeting on August 24 to approve interim results
GLONGHUI, August 9丨GUANZE MEDICAL (02427.HK) announced that the company is scheduled to hold a board meeting on August 24, 2023 (Thursday) to (including) (i) review and appropriately approve the unaudited interim results of the company and its subsidiaries for the six months ended June 30, 2023; (ii) consider issuing interim dividends (if any); and (iii) handle any other matters (if any).
GUANZE MEDICAL: NOTICE OF BOARD MEETING
GUANZE MEDICAL: 2022 ANNUAL REPORT
Revenues Not Telling The Story For Guanze Medical Information Industry (Holding) Co., Ltd. (HKG:2427) After Shares Rise 27%
Guanze Medical Information Industry (Holding) Co., Ltd. (HKG:2427) shares have continued their recent momentum with a 27% gain in the last month alone. Longer-term shareholders would be thankful fo
GUANZE MEDICAL: 2022 Annual Results Announcement for the Year Ended 31 December 2022 and Change of Principal Place of Business in Hong Kong
No Data